IFPMA » New AMR Action Fund steps in to save collapsing antibiotic pipeline with pharmaceutical industry investment of US$1 billion
Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.
Speed is essential, but not at the expense of safety and efficacy, experts warn. Sacrificing either could damage public trust.
Evive Biotech announced today that its Phase III study investigating F-627 to treat chemotherapy-induced neutropenia (CIN) in breast cancer patients has met its primary and secondary ...
COVID-19 has upended the economy, but biotechs with promising medical treatments are still attracting venture capital.
IDbyDNA is advancing the realm of metagenomic testing and playing a role in the fight against COVID-19. The San Francisco-based startup has its lab operations at Salt Lake City’s Research ...
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
However, there is still a lot going on in drug discovery and healthcare, and here I would like to specifically focus on artificial intelligence (AI)-driven biotech and health tech …